Rein Therapeutics Statistics
Total Valuation
RNTX has a market cap or net worth of $32.39 million. The enterprise value is $26.67 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, after market close.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RNTX has 23.31 million shares outstanding. The number of shares has increased by 137.74% in one year.
| Current Share Class | 23.31M |
| Shares Outstanding | 23.31M |
| Shares Change (YoY) | +137.74% |
| Shares Change (QoQ) | +10.37% |
| Owned by Insiders (%) | 1.04% |
| Owned by Institutions (%) | 16.32% |
| Float | 19.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 10.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.86
| Current Ratio | 0.86 |
| Quick Ratio | 0.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -79.38% and return on invested capital (ROIC) is -20.42%.
| Return on Equity (ROE) | -79.38% |
| Return on Assets (ROA) | -18.24% |
| Return on Invested Capital (ROIC) | -20.42% |
| Return on Capital Employed (ROCE) | -48.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.38M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.35% in the last 52 weeks. The beta is 1.31, so RNTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -41.35% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 1.90 |
| Relative Strength Index (RSI) | 58.98 |
| Average Volume (20 Days) | 65,209 |
Short Selling Information
The latest short interest is 26,097, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 26,097 |
| Short Previous Month | 51,478 |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 1.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.35M |
| Pretax Income | n/a |
| Net Income | -59.15M |
| EBITDA | -24.35M |
| EBIT | -24.35M |
| Earnings Per Share (EPS) | -$2.64 |
Full Income StatementBalance Sheet
The company has $5.72 million in cash and n/a in debt, giving a net cash position of $5.72 million or $0.25 per share.
| Cash & Cash Equivalents | 5.72M |
| Total Debt | n/a |
| Net Cash | 5.72M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 48.01M |
| Book Value Per Share | 0.13 |
| Working Capital | -1.09M |
Full Balance SheetCash Flow
| Operating Cash Flow | -21.22M |
| Capital Expenditures | n/a |
| Free Cash Flow | -21.22M |
| FCF Per Share | -$0.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
